Active Research Studies: Colon Cancer

A Phase 2, Open Label Study of Tucatinib Combined with Trastuzumab in Patients with HER2+ Metastatic Colorectal Cancer
Study#: i2773 Phase II
Contact Us: For information about this clinical study, Email Us, or use our form field.

A Global, Multicenter, Randomized, Placebo Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colon Cancer (Fresco-2)
Study#: i2776 Phase II
Contact Us: For information about this clinical study, Email Us, or use our form field.